Affiliation:
1. Department of Physiology, Anatomy and Genetics University of Oxford Oxford UK
Abstract
AbstractThe unique property of the pulmonary circulation to constrict in response to hypoxia, rather than dilate, brings advantages in both health and disease. Hypoxic pulmonary vasoconstriction (HPV) acts to optimise ventilation‐perfusion matching – this is important clinically both in focal disease (such as pneumonia) and in one‐lung ventilation during anaesthesia for thoracic surgery. However, during global hypoxia such as that encountered at high altitude, generalised pulmonary vasoconstriction can lead to pulmonary hypertension. There is now a growing body of evidence that links the hypoxia‐inducible factor (HIF) pathway and pulmonary vascular tone – in both acute and chronic settings. Genetic and pharmacological alterations to all key components of this pathway (VHL – von Hippel–Lindau ubiquitin E3 ligase; PHD2 – prolyl hydroxylase domain protein 2; HIF1 and HIF2) have clear effects on the pulmonary circulation, particularly in hypoxia. Furthermore, knowledge of the molecular biology of the prolyl hydroxylase enzymes has led to an extensive and ongoing body of research into the importance of iron in both HPV and pulmonary hypertension. This review will explore these relationships in more detail and discuss future avenues of research.
image